Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Basal Cell Cancer
|
109 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Basal cell carcinoma
|
109 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Basal Cell Neoplasm
|
109 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Frontal fibrosing alopecia
|
14 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Postmenopausal frontal fibrosing alopecia
|
14 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Respiratory Tract Diseases
|
109 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Endometrial Carcinoma
|
326 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.050 | 1.000 | 5 | 2004 | 2015 | |||||
Malignant neoplasm of endometrium
|
197 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.050 | 1.000 | 5 | 2004 | 2015 | |||||
Breast Carcinoma
|
2793 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.040 | 0.750 | 4 | 2006 | 2015 | |||||
Malignant neoplasm of breast
|
3417 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.040 | 0.750 | 4 | 2006 | 2015 | |||||
Malignant neoplasm of prostate
|
1082 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.040 | 1.000 | 4 | 2008 | 2015 | |||||
Prostate carcinoma
|
1168 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.040 | 1.000 | 4 | 2008 | 2015 | |||||
Colorectal Carcinoma
|
1962 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.020 | 1.000 | 2 | 2012 | 2014 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.020 | 1.000 | 2 | 2012 | 2014 | |||||
Carcinoma of lung
|
1204 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Gastrointestinal Stromal Tumors
|
154 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Glaucoma, Primary Open Angle
|
222 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Malignant neoplasm of lung
|
1142 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Malignant neoplasm of pancreas
|
277 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.010 | 1 | 2010 | 2010 | ||||||
Menopausal symptom
|
4 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Pancreatic carcinoma
|
322 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.010 | 1 | 2010 | 2010 | ||||||
Pancreatic Ductal Adenocarcinoma
|
22 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Patent ductus arteriosus
|
56 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
PATENT DUCTUS ARTERIOSUS 1
|
12 | 0.653 | 0.440 | 2 | 38070996 | missense variant | T/C;G | snv | 0.15; 4.0E-06 | 0.010 | 1.000 | 1 | 2008 | 2008 |